ClinVar Genomic variation as it relates to human health
NM_206933.4(USH2A):c.14074G>A (p.Gly4692Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_206933.4(USH2A):c.14074G>A (p.Gly4692Arg)
Variation ID: 48427 Accession: VCV000048427.62
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1q41 1: 215671031 (GRCh38) [ NCBI UCSC ] 1: 215844373 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 9, 2018 Oct 20, 2024 Mar 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_206933.4:c.14074G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_996816.3:p.Gly4692Arg missense NC_000001.11:g.215671031C>T NC_000001.10:g.215844373C>T NG_009497.2:g.757418G>A O75445:p.Gly4692Arg - Protein change
- G4692R
- Other names
- -
- Canonical SPDI
- NC_000001.11:215671030:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00220 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 0.00220
1000 Genomes Project 30x 0.00234
Trans-Omics for Precision Medicine (TOPMed) 0.00404
The Genome Aggregation Database (gnomAD) 0.00419
The Genome Aggregation Database (gnomAD), exomes 0.00471
Exome Aggregation Consortium (ExAC) 0.00478
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00484
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
USH2A | - | - |
GRCh38 GRCh37 |
7080 | 8575 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Benign (3) |
criteria provided, multiple submitters, no conflicts
|
Feb 26, 2022 | RCV000041750.25 | |
Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Aug 6, 2021 | RCV000669410.10 | |
Benign/Likely benign (6) |
criteria provided, multiple submitters, no conflicts
|
Mar 1, 2024 | RCV000756882.47 | |
Likely benign (2) |
criteria provided, single submitter
|
Jul 1, 2021 | RCV001532872.12 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Sep 25, 2011)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: not provided
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV000065446.6
First in ClinVar: May 03, 2013 Last updated: Aug 26, 2019 |
Comment:
Gly4692Ar in Exon 64 of USH2A: This variant is not expected to have clinical sig nificance because it has been identified in 0.6% (53/8600) of … (more)
Gly4692Ar in Exon 64 of USH2A: This variant is not expected to have clinical sig nificance because it has been identified in 0.6% (53/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS/; rs45549044). (less)
Number of individuals with the variant: 17
|
|
Likely benign
(May 20, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Athena Diagnostics
Accession: SCV001146602.1
First in ClinVar: Jan 19, 2020 Last updated: Jan 19, 2020 |
|
|
Likely benign
(Aug 06, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Usher syndrome type 2A
Retinitis pigmentosa 39
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002807433.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Benign
(Jul 24, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000515239.6
First in ClinVar: Mar 08, 2017 Last updated: Mar 04, 2023 |
Comment:
This variant is associated with the following publications: (PMID: 22004887, 25333064, 25262649, 24944099, 26927203, 19129697, 30245029, 32707200)
|
|
Likely benign
(Sep 19, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Usher syndrome type 2A
Retinitis pigmentosa 39
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000794159.1
First in ClinVar: Aug 05, 2018 Last updated: Aug 05, 2018 |
|
|
Benign
(Feb 09, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000231928.5
First in ClinVar: Jun 28, 2015 Last updated: May 03, 2018 |
Number of individuals with the variant: 4
Sex: mixed
|
|
Likely benign
(Jul 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Usher syndrome type 2A
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV001748647.1
First in ClinVar: Jul 10, 2021 Last updated: Jul 10, 2021 |
Sex: mixed
|
|
Benign
(Feb 26, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV002104139.1
First in ClinVar: Mar 12, 2022 Last updated: Mar 12, 2022 |
Comment:
Variant summary: USH2A c.14074G>A (p.Gly4692Arg) results in a non-conservative amino acid change located in the Fibronectin Type III domain (IPR003961) of the encoded protein sequence. … (more)
Variant summary: USH2A c.14074G>A (p.Gly4692Arg) results in a non-conservative amino acid change located in the Fibronectin Type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0047 in 250890 control chromosomes in the gnomAD database, including 6 homozygotes. Although reported in the literature, to our knowledge, no penetrant association of c.14074G>A in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Eight clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. (less)
|
|
Benign
(Jan 31, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001037459.5
First in ClinVar: Dec 17, 2019 Last updated: Feb 20, 2024 |
|
|
Benign
(Nov 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV000884848.6
First in ClinVar: Feb 18, 2019 Last updated: Feb 20, 2024 |
|
|
Likely benign
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005261737.1
First in ClinVar: Sep 29, 2024 Last updated: Sep 29, 2024 |
|
|
Likely benign
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001246240.26
First in ClinVar: May 09, 2020 Last updated: Oct 20, 2024 |
Comment:
USH2A: BP4, BS2
Number of individuals with the variant: 13
|
|
Benign
(Nov 08, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Usher syndrome type 2A
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV002088237.1
First in ClinVar: Apr 23, 2022 Last updated: Apr 23, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
SD-OCT imaging as a valuable tool to support molecular genetic diagnostics of Usher syndrome type 1. | Kremlikova Pourova R | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2018 | PMID: 29551606 |
Diagnostic exome sequencing in 266 Dutch patients with visual impairment. | Haer-Wigman L | European journal of human genetics : EJHG | 2017 | PMID: 28224992 |
Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. | Pierrache LH | Ophthalmology | 2016 | PMID: 26927203 |
Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT. | Colombo L | Journal of ophthalmology | 2015 | PMID: 26075083 |
Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome. | Krawitz PM | Molecular genetics & genomic medicine | 2014 | PMID: 25333064 |
Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants. | Shearer AE | American journal of human genetics | 2014 | PMID: 25262649 |
Molecular diagnosis of Usher syndrome: application of two different next generation sequencing-based procedures. | Licastro D | PloS one | 2012 | PMID: 22952768 |
Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. | Garcia-Garcia G | Orphanet journal of rare diseases | 2011 | PMID: 22004887 |
Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. | McGee TL | Journal of medical genetics | 2010 | PMID: 20507924 |
Audiometric characteristics of USH2a patients. | Leijendeckers JM | Audiology & neuro-otology | 2009 | PMID: 19129697 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=USH2A | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs45549044 ...
HelpRecord last updated Nov 10, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.